The biopharma world is buzzing right now, and one of the biggest stars stealing the spotlight is the bispecific antibody—better known as the BsAb. These molecular multitaskers can latch onto two different antigens at once, making them an absolute game-changer for tackling complex diseases like cancer. And according to market analysts, the BsAb sector is primed for explosive growth in the...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek